Where does Immortazyme Company Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Immortazyme Company Ltd. ranks #47,620 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Immortazyme Company Ltd. hold?

Immortazyme Company Ltd. holds 5 US utility patents granted between 2018 and 2022, spanning 9 technology areas.

What is Immortazyme Company Ltd.'s Innovation Score?

Immortazyme Company Ltd. has an Innovation Score of 27.3 out of 100 (23rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Immortazyme Company Ltd.'s patent grant rate increasing or decreasing?

Immortazyme Company Ltd.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Immortazyme Company Ltd.'s patents?

Immortazyme Company Ltd.'s patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Immortazyme Company Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Immortazyme Company Ltd.

Q: What technology areas does Immortazyme Company Ltd. focus on?

Immortazyme Company Ltd.'s top technology area is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture) with 2 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 9 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Immortazyme ranks #47,620 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 9 technology areas.

#47,620
of 49,997 US assignees by volume: 23rd percentile
by Innovation Score (27.3/100): 13.8
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47620 · Foreign Corporation #47,620 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,620/49,997
PHOTO-FINISH Imagine Intelligent…
CPC-NARROW C12P · 9 areas
INNOV-THIN 27.3/100
CLAIMS-RICH 13.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Imagine Intelligent Materials Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Immortazyme · this assignee

27
3D Lighting… · lowest

7

What this shows Immortazyme's Innovation Score is 27.3/100 (23rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Immortazyme's grants concentrate

Immortazyme Company Ltd. is a focused PatentsView assignee: 9 CPC subclasses with 40% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2018. By volume, Immortazyme sits between Imagine Intelligent Materials Limited and Immunology Laboratories, Inc..

Immortazyme's three-year grant acceleration

Immortazyme Company Ltd. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Imagine Intellige…

5
Imaginear

5
Imagineering Werks

5
Immersive Wisdom

5
Immudex Aps

5
Immungene

5
Immunomolecular T…

5
Immunology Labora…

5
Immortazyme ◀

5

What this shows Immortazyme holds 5 patents at rank #47,761, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immortazyme

By rank, the assignees closest to #47,761 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Immortazyme's primary technology class.

Immortazyme's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 23rd percentile higher than 23% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Immortazyme Company Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	20.0%
2019	1	20.0%
2021	2	40.0%
2022	1	20.0%

Which technologies does Immortazyme Company Ltd. patent most?

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 2

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 2

E21B - Earth OR Rock DRILLING; Obtaining OIL, GAS, Water, Soluble OR Meltable Materials OR A Slurry OF Minerals From Wells 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

C11B - Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#47,620

of 49,997 tracked assignees

Innovation Score

27.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Immortazyme Company Ltd.'s patent record in context - here's where to go next.

Immortazyme Company Ltd.'s lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 40% of its portfolio - see every assignee active in that class. Explore C12P
Ranked #47,620 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Immortazyme Company Ltd. against Imagine Intelligent Materials Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.